share_log

Esperion Therapeutics And 2 Other Stocks Under $3 Insiders Are Aggressively Buying

Esperion Therapeutics And 2 Other Stocks Under $3 Insiders Are Aggressively Buying

Esperion Therapeutics和其他兩隻低於3美元的股票內部人士正在積極買入
Benzinga ·  2023/05/11 21:25

The Dow Jones closed slightly lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週三收盤小幅走低。當內部人士購買或出售股票時,這表明他們對公司前景的信心或擔憂。對便士股感興趣的投資者和交易者可以將其視爲其整體投資或交易決策中的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是近期一些值得注意的細價股內幕交易。欲瞭解更多,請查看 本辛加的內幕交易 平臺。

Sensus Healthcare

森索斯醫療保健

  • The Trade: Sensus Healthcare, Inc. (NASDAQ:SRTS) Director Samuel O'Rear acquired a total 20,000 shares an average price of $2.99. To acquire these shares, it cost around $59.85 thousand. The company's President and General Counsel also bought the company's shares.
  • What's Happening: Sensus Healthcare reported worse-than-expected Q1 EPS and sales results.
  • What Sensus Healthcare Does: Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system.
  • 交易: Sensus 醫療保健有限公司 (納斯達克股票代碼:SRTS)董事塞繆爾·奧雷爾 共收購了2萬股股票 平均價格爲2.99美元。收購這些股票的成本約爲59.85萬美元。該公司的總裁兼總法律顧問還購買了該公司的股票。
  • 發生了甚麼: Sensus Healthcare公佈的第一季度每股收益和銷售業績均低於預期。
  • Sensus 醫療保健是做甚麼的: Sensus Healthcare Inc從事淺表放射治療系統的製造。

Esperion Therapeutics

Esperion Therapeu

  • The Trade: Esperion Therapeutics, Inc. (NASDAQ:ESPR) President and CEO Sheldon L Koenig acquired a total of 20,000 shares at an average price of $1.26. The insider spent around $25.19 thousand to buy those shares.
  • What's Happening: Esperion Therapeutics posted a wider-than-expected quarterly loss.
  • What Esperion Therapeutics Does: Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol.
  • 這筆交易: Esperion Therapeutics, Inc (納斯達克股票代碼:ESPR)總裁兼首席執行官謝爾登·科尼格 共收購了2萬股股票 平均價格爲1.26美元。內部人士花費了大約25.19萬美元購買了這些股票。
  • 發生了甚麼:Esperion Therapeutics公佈的季度虧損超出預期。
  • Esperion Therapeutics 做: Esperion Therapeutics Inc 是一家制藥公司。它專門爲患有低密度脂蛋白膽固醇升高的患者開發和商業化可獲得的口服、每日一次的非他汀類藥物。

TCR2 Therapeutics

TCR2 療法

  • The Trade: TCR2 Therapeutics Inc. (NASDAQ:TCRR) 10% owner Tang Capital Partners LP acquired a total of 83,988 shares at an average price of $1.95. To acquire these shares, it cost around $163.78 thousand.
  • What's Happening: TCR2 Therapeutics posted a wider Q4 loss.
  • What TCR2 Therapeutics Does: TCR2 Therapeutics Inc is a clinical-stage cell therapy company.
  • 這筆交易: TCR2 Therapeutics Inc (納斯達克股票代碼:TCRR)10% 所有者唐資本合夥人有限責任公司 共收購了 83,988 股股票 平均價格爲1.95美元。收購這些股票的成本約爲163.78萬美元。
  • 發生了甚麼: TCR2 Therapeutics公佈了更廣泛的第四季度虧損。
  • TCR2 Therapeutics 做甚麼: TCR2 Therapeutics Inc 是一家臨床階段的細胞療法公司。

Check This Out: Investor Sentiment Declines Slightly Following Inflation Data

看看這個: 通脹數據公佈後,投資者情緒略有下降

Don't forget to check out our premarket coverage here

別忘了在這裏查看我們的上市前報道

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論